Skip to main content
Menu
Why A COVID-19 Vaccine Trial Would Press Pause

On this week’s episode of PODCAST-19, we discuss the news that AstraZeneca’s COVID-19 vaccine trial has been paused because of a severe side effect for one participant, and how temporarily halting a trial can sometimes mean the process is working as intended.

Don’t want to miss an episode of PODCAST-19, FiveThirtyEight’s weekly look at what we know — and what we know we don’t know — about COVID-19? Subscribe on your favorite podcasting app. For example, here’s where to do it on Apple Podcasts and Spotify.

Anna Rothschild is FiveThirtyEight’s senior producer for video.

Sinduja Srinivasan was the producer for PODCAST-19.

Comments